Urotronic is launching a feasibility trial of its drug-coated balloon in men with narrowed urethras, according to StarTribune.
The Plymouth, Minn.-based company’s Optilume device is inserted into a patient’s urethra and then inflates to dilate the urethra, allowing urine to leave the patient’s bladder.
Get the full story at our sister site, Drug Delivery Business News.